Force Protection at Risk
The case for renewed investment by the U.S. Department of Defense in malaria research and development and prevention.
The case for renewed investment by the U.S. Department of Defense in malaria research and development and prevention.
Evidence-based pathways and principles to support the successful implementation of the America First Global Health Strategy for malaria.
Why strategic health investment is America’s highest-return African deal.
U.S. investments in malaria over the last two decades have saved lives, strengthened economies, and delivered lasting returns.
Investing in malaria prevention and elimination around the world is more than a humanitarian imperative. It is in our national interest.
Exporting malaria solutions to the world through innovation, example, and a thriving biopharmaceutical sector.
In the next 5 years, the world will see new, revolutionary tools to eradicate malaria forever.
Mobilizing and deploying private capital to achieve public health goals.
To scale community fever testing, curb Covid-19 and prevent future pandemics in LMICs.
The case for investing in a gendered approach to the fight against malaria.